Dr. Prashant Kesharwani is an Assistant Professor of Pharmaceutics at Dr. Harisingh Gour Vishwavidyalaya (A Central University), Sagar, India. His work focuses on translational nanomedicine, polymeric biomaterials, targeted drug delivery, nanoengineered drug delivery systems, and translational pharmaceutical research. He has contributed extensively to the scientific literature and has served as an editor of scholarly books. Dr. Kesharwani has received research funding from national agencies and has been recognized with awards and fellowships for his contributions to the field. His research interests include nanomedicine, targeted and stimuli-responsive drug delivery, polymeric nanocarriers, and related pharmaceutical applications. He is actively involved in scientific research, academic mentoring, and scholarly publishing. Dr. Khaled Greish is Professor of Molecular Medicine, and head of the Nano-research unit, at Princes Al-Jawhara Center, Arabian Gulf University, Kingdom of Bahrain. His previous appointments included Senior lecturer of Pharmacology at the University of Otago, New Zealand, and Assistant Professor of Pharmaceutical Chemistry at University of Utah (UT, USA). He has published > 70 peer reviewed papers, and 10 book chapters in the field of targeted anticancer drug delivery. Controlled Release Society (CRS) awarded him the CRS Postdoctoral Achievement Award in 2008 and in 2010; he was elected as member of the CRS College of Fellows. In recognition of his research, University of Otago awarded him “Early Career Awards for Distinction in Research” in 2014. His research focuses on Nanomedicine, tumor vascular biology, and anticancer drug discovery/development.

• Part A: Synthesis and characterization of polymeric micelles for drug delivery1. Polymeric micelles: pre´ cis for past, present, and future2. Various polymers in the development of polymeric micelles3. Solubility enhancement and drug release mechanism of polymeric micelles4. Polymeric micellar nanomedicine for enhanced permeability and retention effect 5. Polymeric micelles for oral drug delivery6. Polymeric micellar nanocarriers: topical treatment of inflammatory diseasesPart B: Application of polymeric micelles in drug delivery7. Polymeric micelles in dermal and transdermal drug delivery8. Polymeric micelles as delivery systems for anticancer immunotherapy9. Polymeric micelles for drug delivery in oncology 10. Surface engineering of polymeric micelles for imparting multifunctionality11. Cellular interaction of polymeric micelles in targeted drug delivery systems: the road from tissue to cellPart C: Stimuli-responsive polymeric micelles for drug delivery12. pH-responsive polymeric micelles for drug delivery13. Enzyme-responsive polymeric micelles for drug delivery applications14. Light- and temperature-responsive polymeric micelles for drug delivery15. Exogenous stimuli 16. Dual-responsive polymeric micelles for drug deliveryPart D: Recent advances in polymeric micelles17. Polymeric micelles for drug codelivery18. Nose-to-brain delivery19. The application of a drug 20. Polymeric micelles with cleavable links for drug delivery21. Block copolymer micelles as long-circulating drug delivery vehicles22. Triblock polymeric micelles as an emerging nanocarrier for drug deliveryPart E: Environmental and regulatory aspects23. Biological toxicity and environmental hazards associated with polymeric micelles24. Clinical translation of polymeric micelles into market25. Regulatory pathways and prospects for polymeric micelles

Dr. Prashant Kesharwani is an Assistant Professor of Pharmaceutics at Dr. Harisingh Gour Vishwavidyalaya (A Central University), Sagar, India. His work focuses on translational nanomedicine, polymeric biomaterials, targeted drug delivery, nanoengineered drug delivery systems, and translational pharmaceutical research. He has contributed extensively to the scientific literature and has served as an editor of scholarly books. Dr. Kesharwani has received research funding from national agencies and has been recognized with awards and fellowships for his contributions to the field. His research interests include nanomedicine, targeted and stimuli-responsive drug delivery, polymeric nanocarriers, and related pharmaceutical applications. He is actively involved in scientific research, academic mentoring, and scholarly publishing. Dr. Khaled Greish is Professor of Molecular Medicine, and head of the Nano-research unit, at Princes Al-Jawhara Center, Arabian Gulf University, Kingdom of Bahrain. His previous appointments included Senior lecturer of Pharmacology at the University of Otago, New Zealand, and Assistant Professor of Pharmaceutical Chemistry at University of Utah (UT, USA). He has published > 70 peer reviewed papers, and 10 book chapters in the field of targeted anticancer drug delivery. Controlled Release Society (CRS) awarded him the CRS Postdoctoral Achievement Award in 2008 and in 2010; he was elected as member of the CRS College of Fellows. In recognition of his research, University of Otago awarded him “Early Career Awards for Distinction in Research” in 2014. His research focuses on Nanomedicine, tumor vascular biology, and anticancer drug discovery/development.

• Part A: Synthesis and characterization of polymeric micelles for drug delivery1. Polymeric micelles: pre´ cis for past, present, and future2. Various polymers in the development of polymeric micelles3. Solubility enhancement and drug release mechanism of polymeric micelles4. Polymeric micellar nanomedicine for enhanced permeability and retention effect 5. Polymeric micelles for oral drug delivery6. Polymeric micellar nanocarriers: topical treatment of inflammatory diseasesPart B: Application of polymeric micelles in drug delivery7. Polymeric micelles in dermal and transdermal drug delivery8. Polymeric micelles as delivery systems for anticancer immunotherapy9. Polymeric micelles for drug delivery in oncology 10. Surface engineering of polymeric micelles for imparting multifunctionality11. Cellular interaction of polymeric micelles in targeted drug delivery systems: the road from tissue to cellPart C: Stimuli-responsive polymeric micelles for drug delivery12. pH-responsive polymeric micelles for drug delivery13. Enzyme-responsive polymeric micelles for drug delivery applications14. Light- and temperature-responsive polymeric micelles for drug delivery15. Exogenous stimuli 16. Dual-responsive polymeric micelles for drug deliveryPart D: Recent advances in polymeric micelles17. Polymeric micelles for drug codelivery18. Nose-to-brain delivery19. The application of a drug 20. Polymeric micelles with cleavable links for drug delivery21. Block copolymer micelles as long-circulating drug delivery vehicles22. Triblock polymeric micelles as an emerging nanocarrier for drug deliveryPart E: Environmental and regulatory aspects23. Biological toxicity and environmental hazards associated with polymeric micelles24. Clinical translation of polymeric micelles into market25. Regulatory pathways and prospects for polymeric micelles

Dr. Prashant Kesharwani is an Assistant Professor of Pharmaceutics at Dr. Harisingh Gour Vishwavidyalaya (A Central University), Sagar, India. His work focuses on translational nanomedicine, polymeric biomaterials, targeted drug delivery, nanoengineered drug delivery systems, and translational pharmaceutical research. He has contributed extensively to the scientific literature and has served as an editor of scholarly books. Dr. Kesharwani has received research funding from national agencies and has been recognized with awards and fellowships for his contributions to the field. His research interests include nanomedicine, targeted and stimuli-responsive drug delivery, polymeric nanocarriers, and related pharmaceutical applications. He is actively involved in scientific research, academic mentoring, and scholarly publishing. Dr. Khaled Greish is Professor of Molecular Medicine, and head of the Nano-research unit, at Princes Al-Jawhara Center, Arabian Gulf University, Kingdom of Bahrain. His previous appointments included Senior lecturer of Pharmacology at the University of Otago, New Zealand, and Assistant Professor of Pharmaceutical Chemistry at University of Utah (UT, USA). He has published > 70 peer reviewed papers, and 10 book chapters in the field of targeted anticancer drug delivery. Controlled Release Society (CRS) awarded him the CRS Postdoctoral Achievement Award in 2008 and in 2010; he was elected as member of the CRS College of Fellows. In recognition of his research, University of Otago awarded him “Early Career Awards for Distinction in Research” in 2014. His research focuses on Nanomedicine, tumor vascular biology, and anticancer drug discovery/development.

• Part A: Synthesis and characterization of polymeric micelles for drug delivery1. Polymeric micelles: pre´ cis for past, present, and future2. Various polymers in the development of polymeric micelles3. Solubility enhancement and drug release mechanism of polymeric micelles4. Polymeric micellar nanomedicine for enhanced permeability and retention effect 5. Polymeric micelles for oral drug delivery6. Polymeric micellar nanocarriers: topical treatment of inflammatory diseasesPart B: Application of polymeric micelles in drug delivery7. Polymeric micelles in dermal and transdermal drug delivery8. Polymeric micelles as delivery systems for anticancer immunotherapy9. Polymeric micelles for drug delivery in oncology 10. Surface engineering of polymeric micelles for imparting multifunctionality11. Cellular interaction of polymeric micelles in targeted drug delivery systems: the road from tissue to cellPart C: Stimuli-responsive polymeric micelles for drug delivery12. pH-responsive polymeric micelles for drug delivery13. Enzyme-responsive polymeric micelles for drug delivery applications14. Light- and temperature-responsive polymeric micelles for drug delivery15. Exogenous stimuli 16. Dual-responsive polymeric micelles for drug deliveryPart D: Recent advances in polymeric micelles17. Polymeric micelles for drug codelivery18. Nose-to-brain delivery19. The application of a drug 20. Polymeric micelles with cleavable links for drug delivery21. Block copolymer micelles as long-circulating drug delivery vehicles22. Triblock polymeric micelles as an emerging nanocarrier for drug deliveryPart E: Environmental and regulatory aspects23. Biological toxicity and environmental hazards associated with polymeric micelles24. Clinical translation of polymeric micelles into market25. Regulatory pathways and prospects for polymeric micelles